About UsProductsNewsClinical TrialCorporate RelationsResources

Clinical Trial Newsletters

Zuragen™ Clinic Poster

Local Article Example

Q & A

Site List

Educational Incentive Program

CRF Re-order Form

CRF Helpful Hints

Hemodialysis Catheter (Material) Types

Temperature Conversion Chart

Volunteers Needed for a
Clinical Research Trial

If you undergo hemodialysis treatments three times each week using a catheter, you may be eligible. Ask your doctor today.

AAT-023 Study

Patients using a catheter to receive hemodialysis treatments may be at risk in getting a Catheter Related Bloodstream Infection (CRBSI). Nearly 1 in every 10 hemodialysis catheters becomes infected each month. As a result of the infection, your physician may recommend additional medicine for treatment or the removal of your catheter.

Ash Access Technology is looking for volunteers who are 18 years of age or older to participate in a study that will determine the effect of an investigational new therapy called AAT-023 which may prevent and reduce the number of catheter-related bloodstream infections. The AAT-023 therapy will be injected into a patient’s catheter (similar to Heparin) between dialysis treatments.

You may be eligible if you are/have:

  • 18 years old or older
  • End stage renal disease (ESRD) requiring 3 hemodialysis treatments each
    week
  • A tunneled and cuffed chronic hemodialysis catheter

The study will last 6-12 months. As a participant in the study, you will receive the study medication (AAT-023) or Heparin in your catheter after each dialysis treatment.

If you are interested in learning more or participating in the study, please contact:

- Click here to download the original PDF of this poster -